Artificial intelligence-based personalized diet: A pilot clinical study for irritable bowel syndrome
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
We enrolled consecutive IBS-M patients (n = 25) according to Rome IV criteria. Fecal samples were obtained from all patients twice (pre-and post-intervention) and high-throughput 16S rRNA sequencing was performed. Six weeks of personalized nutrition diet (n = 14) for group 1 and a standard IBS diet (n = 11) for group 2 were followed. AI-based diet was designed based on optimizing a personalized nutritional strategy by an algorithm regarding individual gut microbiome features. The IBS-SSS evaluation for pre- and post-intervention exhibited significant improvement (p < .02 and p < .001 for the standard IBS diet and personalized nutrition groups, respectively). While the IBS-SSS evaluation changed to moderate from severe in 78% (11 out of 14) of the personalized nutrition group, no such change was observed in the standard IBS diet group. A statistically significant increase in the Faecalibacterium genus was observed in the personalized nutrition group (p = .04). Bacteroides and putatively probiotic genus Propionibacterium were increased in the personalized nutrition group. The change (delta) values in IBS-SSS scores (before-after) in personalized nutrition and standard IBS diet groups are significantly higher in the personalized nutrition group. AI-based personalized microbiome modulation through diet significantly improves IBS-related symptoms in patients with IBS-M. Further large-scale, randomized placebo-controlled trials with long-term follow-up (durability) are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Cohen, J. (2013) · doi:10.4324/9780203771587 · Cited by 25,373
Larian Studios Dev Team (2024) · doi:10.1145/3292500.3330701 · Cited by 8,618 · cited 1×
“The hyperpara-meters of the XGBoost model were optimized using the Bayesian optimization tool Optuna 34 in a five-fold-cross validation setting.”
MethodOlejnik, S., & Algina, J. (2003) · Psychological Methods · doi:10.1037/1082-989x.8.4.434 · Cited by 1,622 · cited 2×
“To observe the correlation between micro-biota-derived IBS scores with the clinical evaluations (i.e. IBS-SSS), we have measured the explained variance, omega-squared statistics ( ω, 2 ,15 and Cohen’s f 2 statistics 16 of IBS-SSS concerning microbiota scores.”
MethodInfluentialA Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome
Halmos, E. P., Power, V. A., Shepherd, S. J., Gibson, P. R., & Muir, J. G. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.09.046 · Cited by 1,249
Rajilić–Stojanović, M., Biagi, E., Heilig, H. G. H. J., Kajander, K., Kekkonen, R. A., Tims, S., & de Vos, W. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.043 · Cited by 1,041
Gut Microbiota in Patients With Irritable Bowel Syndrome—A Systematic Review
Pittayanon, R., Lau, J. T., Yuan, Y., Leontiadis, G. I., Tse, F., Surette, M., & Moayyedi, P. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.03.049 · Cited by 719 · cited 7×
“In a recent systematic review, the Ruminococcaceae family and Faecalibacterium genus were not different in IBS vs healthy groups.(23) Although there are inconsistencies between the literature and our results, these differences might stem from patients’ geographic, cultural, and dietary habits.”
BackgroundResultInfluentialDeschasaux, M., Bouter, K. E., Prodan, A., Levin, E., Groen, A. K., Herrema, H., Tremaroli, V., Bakker, G. J., Attaye, I., Pinto-Sietsma, S.-J., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0160-1 · Cited by 695 · cited 1×
“A recent systematic review of 24 studies performed before 2018 has found that while there was some overlap, none of the studies reported the same differences in gut microbiota.(8,9) This inconsistency can be the result of a unique microbiome composition for each patient and each disease state.”
ResultGastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome
Saulnier, D. M., Riehle, K., Mistretta, T., Diaz, M., Mandal, D., Raza, S., Weidler, E. M., Qin, X., Coarfa, C., Milosavljevic, A., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.072 · Cited by 672
Tap, J., Derrien, M., Törnblom, H., Brazeilles, R., Cools-Portier, S., Doré, J., Störsrud, S., Le Nevé, B., Öhman, L., & Simrén, M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.09.049 · Cited by 642
Carroll, I. M., Ringel‐Kulka, T., Siddle, J. P., & Ringel, Y. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01891.x · Cited by 425 · cited 1×
“4 Some investigators reported increased fecal Streptococcus 5 and Proteobacteria levels in the gut mucosa.”
BackgroundGastrointestinal microbiota in irritable bowel syndrome: present state and perspectives
Salonen, A., de Vos, W. M., & Palva, A. (2010) · Microbiology · doi:10.1099/mic.0.043257-0 · Cited by 264 · cited 1×
“The alteration of gut microbiota composition in the IBS context has been repeatedly reported by observational studies.(4) Some investigators reported increased fecal Streptococcus(5) and Proteobacteria levels in the gut mucosa.”
BackgroundRigsbee, L., Agans, R., Shankar, V., Kenche, H., Khamis, H. J., Michail, S., & Paliy, O. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.287 · Cited by 207
DuPont, H. L. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12728 · Cited by 171 · cited 1×
“The pathophysiology of IBS is complex, but recent evidence suggests that the gut microbiome may play an essential role in the development, progression, and severity of these symptoms.(3) The advent of next-generation sequencing has increased investigations to identify changes in the gut microbiome related to IBS.”
BackgroundThe Gut Microbiome and Individual-Specific Responses to Diet
Leshem, A., Segal, E., & Elinav, E. (2020) · mSystems · doi:10.1128/msystems.00665-20 · Cited by 109
No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population
Hugerth, L. W., Andreasson, A., Talley, N. J., Forsberg, A. M., Kjellström, L., Schmidt, P. T., Agreus, L., & Engstrand, L. (2020) · Gut · doi:10.1136/gutjnl-2019-318717 · Cited by 102 · cited 1×
“A recent systematic review of 24 studies performed before 2018 has found that while there was some overlap, none of the studies reported the same differences in gut microbiota.(8,9) This inconsistency can be the result of a unique microbiome composition for each patient and each disease state.”
Result
Cited by
Theodore Armand, T. P., Nfor, K. A., Kim, J.-I., & Kim, H.-C. (2024) · Nutrients · doi:10.3390/nu16071073 · Cited by 253
“An adjacent possibility created a flow between the clusters to ensure a complete and effective AI-assisted nutrition system (see Figure 7”
Abavisani, M., Khoshrou, A., Foroushan, S. K., Ebadpour, N., & Sahebkar, A. (2024) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2024.100211 · Cited by 75
Han, X., Liu, Q., Li, Y., Zhang, M., Liu, K., Kwok, L.-Y., Zhang, H., & Zhang, W. (2025) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2025.104938 · Cited by 64
Understanding the Functionality of Probiotics on the Edge of Artificial Intelligence (AI) Era
Asar, R., Erenler, S., Devecioglu, D., Ispirli, H., Karbancioglu-Guler, F., Ozturk, H. I., & Dertli, E. (2025) · Fermentation · doi:10.3390/fermentation11050259 · Cited by 37
Metadata
- Authors
- Karakan, T., Gundogdu, A., Alagözlü, H., Ekmen, N., Ozgul, S., Tunali, V., Hora, M., Beyazgul, D., & Nalbantoglu, O. U.
- Venue
- Gut Microbes
- Publisher
- Informa UK Limited
- Published
- 2022-11
- Volume
- 14
- Issue
- 1
- Pages
- 2138672-2138672
- ISSN
- 1949-0976 (ISSN-L)
- 1949-0984
- OpenAlex
- W4308024347
- Cited by
- 79
- References
- 15
- FWCI
- 11.12
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.